Home

Articles from Waldencast plc

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
Acquisition strengthens Obagi Medical’s product portfolio with proven, scientifically backed, injectable portfolio
By Waldencast plc · Via GlobeNewswire · July 23, 2025